Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.
Saved in:
| Title: | Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study. |
|---|---|
| Authors: | Zhang, Yunlin1,2 (AUTHOR), Patel, Ruchi P.1,2 (AUTHOR), Kim, Ki Hyun3 (AUTHOR), Cho, Hyungwoo4 (AUTHOR), Jo, Jae-Cheol5 (AUTHOR), Jeong, Seong Hyun6 (AUTHOR), Oh, Sung Yong7 (AUTHOR), Choi, Yoon Seok6 (AUTHOR), Kim, Sung Hyun7 (AUTHOR), Lee, Ji Hyun7 (AUTHOR), Angelos, Mathew1,2 (AUTHOR), Guruprasad, Puneeth1,2 (AUTHOR), Cohen, Ivan1,2 (AUTHOR), Ugwuanyi, Ositadimma1,2 (AUTHOR), Lee, Yong Gu1,2,8 (AUTHOR), Pajarillo, Raymone1,2 (AUTHOR), Cho, Jong Hyun9 (AUTHOR), Carturan, Alberto1,2 (AUTHOR), Paruzzo, Luca1,2 (AUTHOR), Ghilardi, Guido1,2 (AUTHOR) |
| Source: | Molecular Cancer. 12/9/2023, Vol. 22 Issue 1, p1-23. 23p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
